Mineralys Therapeutics director Daphne Karydas sells 3,000 shares for $85,740
MLYS•Director sells shares after exercising options
- Mineralys Therapeutics director Daphne Karydas sold 3,000 common shares at USD 28.58 on Sep. 15, 2026.
- She exercised stock options for 3,000 shares at USD 12.02 in a same-day transaction.
- Directly held common stock position fell to 6,200 shares following the trades.
Related News
Ameren wins Illinois approval for 21-mile Illinois Valley transmission line project
AEE•
BlackRock MuniYield Quality Fund director Francis C. Mahoney files initial beneficial ownership statement
MQY•
